Numan monetizes menopause through employers

Women’s health gives Numan a new way to sell the same care engine through employers, not just through paid social and direct subscriptions. Menopause care fits neatly into Numan’s existing model because it involves repeated questionnaires, clinician review, prescriptions, blood tests, coaching, and ongoing symptom management over years. That makes it easier to package as a workplace benefit tied to retention, absence reduction, and support for midlife employees.

• The UK market is moving from awareness to formal employer action. More than 2,600 employers have signed the Menopause Workplace Pledge, and new UK guidance published on March 4, 2026 explicitly includes menopause support in voluntary action plans linked to gender pay gap reporting for employers with 250 or more staff.
  2 gov 3 campaign 5 gov
• The closest playbook comes from women’s health benefits platforms. Maven sells menopause support to employers as part of a broader family and women’s health benefit, and announced a global menopause program with BSI in January 2024. That shows employers will buy this category when it is framed as workforce support, not only medical care.
  4 sacra 6 sacra 7 mavenclinic
• For Numan, the practical advantage is operational reuse. Its app already handles remote intake, clinician messaging, pharmacy fulfillment, diagnostics, and subscription follow up across chronic conditions. Menopause lets that same workflow serve a new population without building a completely different delivery model.
  1 sacra 4 sacra

The next step is a hybrid model where women’s health drives both consumer subscriptions and B2B contracts. If Numan can prove that its menopause offering improves symptom control and keeps employees engaged in work, employer packages can become a lower cost acquisition channel and a more stable revenue layer than pure D2C telehealth.